Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 3/2002

01-09-2002 | Article

Specificity of MOC-31 and HBME-1 immunohistochemistry in the differential diagnosis of adenocarcinoma and malignant mesothelioma: a study on environmental malignant mesothelioma cases from Turkish villages

Authors: Derya Gümürdülü, E. Handan Zeren, Philip T. Cagle, Fazilet Kayaselçuk, Nazan Alparslan, Ali Kocabas, Ilhan Tuncer

Published in: Pathology & Oncology Research | Issue 3/2002

Login to get access
Metadata
Title
Specificity of MOC-31 and HBME-1 immunohistochemistry in the differential diagnosis of adenocarcinoma and malignant mesothelioma: a study on environmental malignant mesothelioma cases from Turkish villages
Authors
Derya Gümürdülü
E. Handan Zeren
Philip T. Cagle
Fazilet Kayaselçuk
Nazan Alparslan
Ali Kocabas
Ilhan Tuncer
Publication date
01-09-2002
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 3/2002
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/BF03032393

Other articles of this Issue 3/2002

Pathology & Oncology Research 3/2002 Go to the issue

Article

Expression of CD44s in human colorectal cancer

Case Report

Combined occurrence of prostate carcinoma and malacoplakia

Article

Comparison of prognostic significance of serum 5-S-Cysteinyldopa, LDH and S-100B protein in Stage III–IV malignant melanoma

Seminar

Molecular pathology of tumor metastasis

Article

Prevalence of mycosis fungoides and its association with EBV and HTLV-1 in Pakistanian patients

In Memoriam

Outstanding cancerologist Leon M Shabad and his scientific activity (100th anniversary)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits